TITLE

Antiretroviral Therapy Is Associated with Reduced Serologic Failure Rates for Syphilis among HIV-Infected Patients

AUTHOR(S)
Ghanem, Khalil G.; Moore, Richard D.; Rompalo, Anne M.; Erbelding, Emily J.; Zenilman, Jonathan M.; Gebo, Kelly A.
PUB. DATE
July 2008
SOURCE
Clinical Infectious Diseases;7/15/2008, Vol. 47 Issue 2, p258
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Syphilis and human immunodeficiency virus (HIV) frequently coexist in patients, but the effects of immunosuppression on the course of syphilis are unknown. Our goal was to determine whether the degree of HIV-mediated immunosuppression and the use of highly active antiretroviral therapy impact syphilis serologic responses. Methods. We assessed all cases of syphilis with positive serologic test results from 1990 through 2006 in a prospective, observational clinical cohort of HIV-infected patients. We defined seroreversion as the loss of reactivity in a patient who previously had a serologic test result positive for syphilis. We defined serologic failure as the lack of a 4-fold decrease in rapid plasma reagin titers 270-365 days after therapy or a 4-fold increase in titers ⩾30 days after therapy. We used Cox proportional hazards models with statistical adjustments for multiple failure instances. Results. One hundred eighty subjects experienced 231 cases of syphilis. The median follow-up time was 5.3 years. A total of 71 episodes of serologic failure were documented. A CD4 cell count of <200 cells/mL at the time of syphilis diagnosis was associated with an increased risk of serologic failure (adjusted hazard ratio, 2.48; 95% confidence interval, 1.26-4.88). The receipt of highly active antiretroviral therapy was associated with a 60% reduction in the rate of serologic failure (adjusted hazard ratio, 0.40; 95% confidence interval, 0.21-0.75), independent of concomitant CD4 cell response. Rapid plasma reagin seroreversion was infrequent (16.1%) and inconsistent, and it was more likely to occur among patients who received macrolides. Conclusion. The use of highly active antiretroviral therapy to reverse immunosuppression and the routine use of macrolides for the prevention of opportunistic infections may reduce syphilis serologic failure rates among HIV-infected patients who have syphilis.
ACCESSION #
32810396

 

Related Articles

  • Long-Term Remission in Progressive Multifocal Leukoencephalopathy Caused by Idiopathic CD4+ T Lymphocytopenia: A Case Report. Rueger, M. A.; Miletic, H.; Dorries, K.; Wyen, C.; Eggers, C.; Deckert, M.; Faetkenheuer, G.; Jacobs, A. H. // Clinical Infectious Diseases;4/1/2006, Vol. 42 Issue 7, pE53 

    Progressive multifocal leukoencephalopathy is caused by JC virus, an opportunistic infection of the central nervous system. Antiretroviral treatment for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients is beneficial, but few data exist for patients who...

  • Single-Dose Fluconazole versus Standard 2-Week Therapy for Oropharyngeal Candidiasis in HIV-Infected Patients: A Randomized, Double-Blind, Double-Dummy Trial. Hamza, Omar J. M.; Matee, Mecky I. N.; Brüggemann, Roger J. M.; Moshi, Mainen J.; Simon, Elison N. M.; Mugusi, Ferdinand; Mikx, Frans H. M.; van der Lee, Henrich A. L.; Verweij, Paul E.; van der Ven, André J. A. M. // Clinical Infectious Diseases;11/15/2008, Vol. 47 Issue 10, p1270 

    Background. Oropharyngeal candidiasis is the most common opportunistic infection affecting patients with human immunodeficiency virus (HIV) infection. Because of convenience, cost, and reluctance to complicate antiretroviral treatment regimens, single-dose fluconazole may be a favorable regimen...

  • Delayed Progression to Death and to AIDS in a Hong Kong Cohort of Patients with Advanced HIV Type 1 Disease During the Era of Highly Active Antiretroviral Therapy. Ka Hing Wong; Kenny Chi Wai Chan; Shui Shan Lee // Clinical Infectious Diseases;9/15/2004, Vol. 39 Issue 6, p853 

    Background. The magnitude of the impact of highly active antiretroviral therapy (HAART) since its introduction in non-Western countries is not entirely clear. We studied disease progression among adult patients with advanced human immunodeficiency virus type 1 (HIV-1) infection in the pre-HAART...

  • Hansen's Disease with HIV: A Case of Immune Reconstitution Disease. Chow, Dominic; Okinaka, Leila; Souza, Scott; Shikuma, Cecilia; Tice, Alan // Hawaii Medical Journal;Mar2009, Vol. 68 Issue 2, p27 

    Immune reconstitution inflammatory syndrome (IRIS) is an acute symptomatic expression of a latent infection during the recovery of the immune system usually as a response to antiretroviral therapy (ART). Opportunistic infections can trigger IRIS. Hansen's disease is an infection caused by...

  • Interventricular septal abscess formation in an HIV-positive man. Almond, D. S.; Lea, B .I; Saltissi, S.; Neal, T. J.; Carey, P. B. // International Journal of STD & AIDS;Nov1999, Vol. 10 Issue 11, p749 

    The natural history of HIV disease has changed dramatically since the advent of more effective antiretroviral therapies with a 6-fold reduction in the 3 commonest opportunistic infections between 1995 and 19971. Given the changing pattern of HIV, it is likely that new clinical problems will...

  • Adherence to Antiretroviral Therapy: How Much Is Enough? Gulick, Roy M. // Clinical Infectious Diseases;10/1/2006, Vol. 43 Issue 7, p942 

    The article presents a study on the efficiency of the antiretroviral therapy. It has been stated that the development of effective antiretroviral therapy in the resulted to significant virologic suppression and immune reconstitution and resulted in dramatic reductions in HIV-related morbidity...

  • Uptake of HIV testing and treatment in an isolated population with access to free and universal healthcare. Gillieatt, Sue J.; Mallal, Simon A.; Gillieatt, S J; Mallal, S A // International Journal of STD & AIDS;May2000, Vol. 11 Issue 5, p303 

    This Western Australian study analysed clinical information from 344 people with AIDS, and experiential data from a sample of 36 people with AIDS to investigate 2 relevant issues: the timing of HIV testing and uptake and experiences of HIV drug treatment. We found that the proportion of people...

  • Prosecuting for knowingly transmitting HIV is warranted. Berger, Philip B. // CMAJ: Canadian Medical Association Journal;6/23/2009, Vol. 180 Issue 13, p1368 

    The article presents the author's views regarding the prosecution of intentional or reckless transmission of HIV to others. The author suggests that reasonable starting point of the transmission behaviour should be established to prosecute justifiably the criminals. The author urges that person...

  • CD4+ Count—Guided Interruption of Antiretroviral Treatment.  // New England Journal of Medicine;11/30/2006, Vol. 355 Issue 22, p2283 

    Background: Despite declines in morbidity and mortality with the use of combination antiretroviral therapy, its effectiveness is limited by adverse events, problems with adherence, and resistance of the human immunodeficiency virus (HIV). Methods: We randomly assigned persons infected with HIV...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics